- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Acute hepatic porphyria (AHP)
- Meeting Date: November 2025
- Public Summary Document (PSD) July 2025 November 2025 PBAC Meetings - (PDF 1.1MB)
- Public Summary Document (PSD) July 2025 November 2025 PBAC Meetings - (Word 496KB)
Related Public Summary Documents
